63 results
6-K
EX-99.1
THTX
Theratechnologies Inc.
21 Feb 24
Theratechnologies Reports Financial Results
8:00am
suppliers will be able to meet market demands for our products; (vii) no dispute or litigation will occur between the Company and our main suppliers; (viii … the Marathon Credit Agreement as immediately due and payable; (vi) dispute or litigation with our suppliers; (vii) the non-approval by the FDA of the F8
F-3
THTX
Theratechnologies Inc.
21 Dec 23
Shelf registration (foreign)
1:21pm
States Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking information may include, but is not limited to, statements
6-K
EX-99.1
THTX
Theratechnologies Inc.
26 Oct 23
Current report (foreign)
9:15pm
or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.
-11-
(v) No Litigation. Except as set forth in the Registration … no knowledge that any such Governmental Authority or third party is considering any such claim, litigation, arbitration, action, suit, investigation
SUPPL
THTX
Theratechnologies Inc.
26 Oct 23
Supplemental materials (foreign)
9:13pm
, and by the United States Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking information may include, but is not limited … or significant declines in the market price of a company’s securities, there have been instances of securities class action litigation being instituted
SUPPL
pfczc5uq5n xmp0e
25 Oct 23
Supplemental materials (foreign)
6:56pm
6-K
EX-99.2
m9gie
21 Jul 22
Material Change Report
4:40pm
6-K
EX-99.1
vuqnuric0qw2v5ynvr
14 Apr 22
Current report (foreign)
4:27pm
40-F
EX-99.2
bdgkep
24 Feb 22
Annual report (Canada)
8:02am
40-F
EX-99.1
qcq2o9 pz9
24 Feb 22
Annual report (Canada)
8:02am
SUPPL
jc0kk0sfcr 1enki
17 Dec 21
Supplemental materials (foreign)
2:42pm
F-10/A
cwsbuij4aixz
15 Dec 21
Registration of securities (Canada) (amended)
4:52pm
F-10
tu6k5x
23 Nov 21
Registration of securities (Canada)
6:13am
SUPPL
gky3k42fda 47j6s58me
26 Jul 21
Supplemental materials (foreign)
12:00am
6-K
EX-99.1
asgapa6rx6 ah
26 Jul 21
Controlled Equity OfferingSM
12:00am
40-F
EX-99.1
kf706fcsm
25 Feb 21
Annual report (Canada)
8:31am
40-F
EX-99.5
qsqslzhhmb6hrvbjaeqh
25 Feb 21
Annual report (Canada)
8:31am
40-F
EX-99.2
aws6nwpa74
25 Feb 21
Annual report (Canada)
8:31am
6-K
EX-99.2
p7leg11171chlzsbup
15 Jul 20
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
kkiph
15 Jul 20
Theratechnologies Announces Financial Results
7:30am